WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

THE OVER-THE-COUNTER PHARMACEUTICAL MARKET. A PHARMACOECONOMIC ANALYSIS

Tsvetkova*, A. Todorova, M. Arnaoudova, M. Dimitrov, E. Atanasova

ABSTRACT

The resource analysis in health care is of particular importance since resources are of fundamental importance to both market and non-market economic activities. The economic analysis in health care is an accurate reflection of the system, that is, it is an economic analysis of the supply, encompassing the provision, allocation and usage of resources. The pharmacoeconomic analysis is the application of the methods of economic analysis for the assessment of alternative drug therapies and their social cost and consequences with respect to the highly fragmented and specific pharmaceutical market. For the
purposes of this article, we consider suitable the application of the cost-minimization analysis of two OTC antihistamine drugs for allergic rhinitis and their corresponding generic substitutes. Allergic rhinitis is a global health problem and a serious socioeconomic burden, and it is a risk factor for the development of asthma. According to a Eurostat survey, untreated allergies result in 10% reduced performance at work; 60 days with symptoms generate an annual loss of 34 work hours per worker, which is estimated approximately at 1000 € productivity loss.

Keywords: allergic rhinitis, cost-minimization, generic OTC antihistamines, pharmaceutical policy.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More